CASP3 and esophageal squamous cell carcinoma: In the context of esophageal squamous cell carcinoma (ESCC), photodynamic therapy (PDT) has been shown to directly inhibit PKM2, thereby activating the PKM2/caspase-8/caspase-3/GSDME axis.